The US-listed company LIXTE has invested $2.6 million in cryptocurrency, increasing its allocation ratio to 50%
ChainCatcher news, Nasdaq-listed company LIXTE Biotechnology Holdings (stock codes: LIXT and LIXTW) announced on September 10 that it has purchased 10.5 Bitcoin and 300 Ethereum for a total value of approximately $2.6 million as part of its diversification strategy.
According to the announcement, cryptocurrencies currently account for 43.6% of LIXTE's capital holdings, and the company's board has approved increasing the allocation of cryptocurrency to 50%. LIXTE Chairman and CEO Geordan Pursglove stated that this move aims to build a balanced and flexible digital asset strategy, enhancing the company's adaptability and long-term growth potential in the digital economy. Previously, it was reported that the U.S. listed biotech company LIXTE plans to allocate up to 25% of its capital reserves to digital assets such as Bitcoin.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.






